The study demonstrates that the sources of reactive oxygen species change with atrial remodeling duration, explaining why statins may prevent postoperative AF but are ineffective in managing permanent AF.
No takes yet. Share an insight, caveat, or question.
ROS sources shift with AF duration, limiting statin benefit in permanent cases; hypothesis-generating for duration-tailored therapies.
Reilly et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: